Alkylated Ni-Gly-BPB Complex (S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-methylhept-6-enoic acid
The amino acid was synthesized according to the method previously described. 1 Crystallisation of the alkylated nickel (II) Schiff base complex from a toluene/pentane solution prior to isolation and Fmoc protection of the amino acid confirmed the stereochemistry (see below for details of the single crystal diffraction study).
Measurements were carried out at 100K on an Agilent Supernova diffractometer equipped with an
Atlas CCD detector and connected to an Oxford Cryostream low temperature device using graphite monochromated Cu K radiation ( = 1.54184 Å) from a Microfocus Nova X-ray source. The structure was solved by direct methods using SHELXS 2 and refined using SHELX97. The compound crystallised as orange plates in a monoclinic cell and was solved in the P21 space group, with two molecules in the asymmetric unit. Most non-hydrogen atoms were located in the Fourier Map and refined anisotropically. There was disorder around the aromatic ring of one of the benzyl groups (C34 to C39). This was refined as two rings each with 50% occupancy. C34, C35A to C39A and C35B to C39B were refined isotropically. All hydrogen atoms were placed in calculated positions and refined isotropically using a "riding model". 
Procedures for peptide synthesis

Synthesis of BID peptides
Synthesis was as described previously 1
General Regards
All amino acids and resins were purchased from either Novabiochem (Merck) or Sigma-Aldrich. All amino acids were N-Fmoc protected and side chains were protected with Boc (Lys, Trp); O t Bu (Asp, Glu, Ser, Thr); Trt (Cys, Asn, Gln); Pbf (Arg). Synthesis of peptides was performed either manually using fritted SPE reservoirs and vacuum filtration tank or by the use of a microwave assisted automated peptide synthesiser (CEM Liberty). DMF used in peptide synthesis was of ACS grade from Sigma-Aldrich.
Methods for Manual Fmoc Solid Phase Peptide Synthesis
Method A: Resin Swelling
The required quantity of resin was placed in a fritted empty SPE tube and CH2Cl2 (2 ml) was added and the resin was agitated on a Stuart Rotator-SB2 for 2 h to allow swelling of the resin.
Method B: Deprotection of N-Fmoc protecting groups
N-terminal Fmoc protecting groups were removed by the addition of 20% piperidine: DMF (5 × 2 mL × 2 min), followed by rinsing the resin with DMF (5 × 2 mL × 2 min). Successful deprotection was determined by a positive colour test (Methods C & D).
Method C: Kaiser Test 4
The Kaiser Test was employed for the determination of the successful coupling or deprotection for most of the residues. A small number of resin beads were rinsed in ethanol and placed in a vial, followed by the addition of two drops of each of the three solutions in the following order:
2) Phenol (80% w/v) in ethanol;
3) 1 mM KCN(aq.) in pyridine (2% v/v).
The solution was then heated to ca. 150 °C for 1 min. A successful coupling gave no change in the colour of the beads, whereas bright blue beads illustrate a successful deprotection. This colour test was useful for the identification of free primary amines, however inconclusive results are obtained for Asp, Ser, Pro and Asn residues.
Method D: Chloranil Test 5
The chloranil test was also employed for the determination of successful couplings or deprotections of some residues. A small number of beads were rinsed in ethanol and placed in a vial, followed by the addition of two drops of each of the two solutions in the following order:
The solution was left at rt for 5 min. No change in colour of the beads showed a negative result, whereas the change of bead colour to pale green/bright blue illustrated a successful deprotection.
This test was especially useful for Pro residues, where the bead colour became a very bright blue (often after 10 seconds) to show a free secondary amine. However, the length of time (often ~10 min for a primary amine) for the colour change made this colour test less useful than the Kaiser test for the determination of free primary amines.
Method E: Coupling of Amino Acids with Uronium Coupling Reagents
The desired amino acid (5 equiv.), DIPEA (5 equiv.), HOBt (5 equiv.) and Uronium coupling reagent (Either HATU, HBTU or HCTU) (5 equiv.) were dissolved in DMF (2 mL) and added to the resin, followed by agitation for 1 h (2 h for unnatural amino acids). For double couplings, this step was repeated. After removal of the reagents by filtration, the resin was washed with DMF (3 × 2 mL × 2 min) and the success of coupling determined by a negative colour test (Methods C & D).
Deprotection of the Fmoc-protected N-terminus then followed (Method B).
Method F: Coupling of Cysteine
The amino acid (5 equiv.), 2,4,6-trimethylpyridine (5 equiv.) and HCTU (5 equiv.) were dissolved in 1:1 CH2Cl2:DMF (2 mL) and added to the resin, followed by agitation for 1 h. After draining the reagents, the resin was washed with DMF (3 × 2 mL × 2 min) and the success of coupling determined by a negative colour test (Methods C & D).
Method G: N-terminal acetylation
Acetic anhydride (10 equiv.) and DIPEA (10 equiv.) were dissolved in DMF (2 mL) and the solution was transferred to the resin. After 2 h, the resin was drained, washed with DMF (3 × 2 mL × 2 min) and successful capping determined by a negative colour test (Methods C & D).
Method H: N-terminal FITC labelling 6
Fluorescein isothiocyanate (1.2 equiv.) was dissolved in 12:8:5 Pyridine:DMF:CH2Cl2 (2 mL) and the solution transferred to the resin in the dark. After 18 h, the resin was washed with DMF (5 × 2 mL × 2 min) ahead of cleavage and deprotection (Method K). The solvents were of anhydrous grade and the pyridine distilled prior to use.
Method J: On-Resin Olefin Metathesis
After the completed peptide elongation and N-terminal acetylation, on-resin olefin metathesis was completed by the preparation of a 10 mM solution of Grubbs First Generation Catalyst in degassed dichloroethane (2 mL), which was added to the resin beads and allowed to agitate gently for 2 h, after which time the metathesis procedure was repeated for another 2 h. N-terminally acetylated peptides were then cleaved from the resin (Method K). For FITC labelled peptides, metathesis was performed before labelling (Method H).
Method K: Cleavage and deprotection of Rink Amide MBHA resin
After elongation and N-terminal acetylation was complete, the resin was washed with DMF The resulting oil was precipitated with ice-cold ether (10 mL) and placed in a centrifuge (3000 rpm × 0.5 min). The supernatants were removed, the precipitate rinsed with ice-cold ether (3 × 10 mL) and dried in vacuo.
Cycles for automated peptide synthesis
Peptides that were built on the microwave assisted Liberty CEM Peptide Synthesiser followed this cycle:
Resin Loading
Clean reaction vessel; wash with DMF; wash with CH2Cl2; transfer resin to reaction vessel; wash with DMF; wash with CH2Cl2; transfer resin to reaction vessel; wash with DMF; wash with CH2Cl2; vessel draining.
Deprotection and coupling
Clean resin dip tube, wash with DMF (15 mL), add 20% piperidine in DMF (6 mL), microwave method (30 sec), wash with DMF (15 mL), add 20% piperidine in DMF (6 mL), microwave method (30 sec), wash with DMF (15 mL), clean resin dip tube, wash with DMF (15 mL), add amino acid (2.5 mL), add coupling reagent (1 mL), add activator base (0.5 mL), microwave method (5 min), wash with DMF (15 mL), drain.
For methods that did not use microwave assistance, the reaction cycle was the same, except the microwave method for deprotection and coupling was replaced by agitation of the resin at rt for 10 min and 90 min respectively.
After the final residue, the resin was ejected from the reaction vessel and cleavage/deprotection was performed manually using Methods K-M.
Peptide Purification
Peptides were purified by preparative scale HPLC using a Jupiter Proteo preparative column 
Synthesis of FITC-labelled BID peptides
Synthesis of BIM peptides
The BIM series of peptides (BIM MM and BIM DM) were synthesized on Rink Amide MBHA LL resin BIM-MM 9.2 mg (23% based on 40 mg purified) and BIM-DM 21.6 mg (32% of 0.038 mmol purified).
Below are tabulation HRMS data of the peptides that have been synthesised. Peptide identity was confirmed by the inspection of multiple charge states and are quoted as the monoisotopic peak for 
HPLC, ESI-MS and LC-MS Data for peptides
Data for BID-WT,BID-Aib BID-MM and BID-DM has previously been published 1 ; these peptides were resynthesized here and gave comparable data.. Synthesis and purification of (i) BAK and BODIPY-BAK 1 and (ii) FITC-NOXA-B and NOXA B 7 were described previously. These reagents were available from the previous work and were not resynthesized.
BAD was purchased from Peptide and Protein Research Ltd.
Shoulders in some of the LC and HPLC traces are due to cis/trans isomers and where applicable, arises from the use of mixed isomers of FITC for peptide synthesis. The raw circular dichroism data obtained for the peptides was processed by the subtraction of the solvent signal and converted into a mean residue ellipticity:
Where θ = circular dichroism at a given wavelength, c = molar concentration, l = path length in cm, R = number of residues in the peptide sequence.
Calculation of % Helicity was performed by the following equation:
9
Where: Θ = Theoretical MRE for 100% helicity at 222 nm, Θ(0) = Theoretical MRE for 100% helicity at 222 nm at 0 °C = -44000, (∂Θ/∂T) = temperature dependence of infinite helix = +250, T = temperature in °C, x = 3, Nr = number of residues in a peptide. Figure S1 . Additional CD spectra (a) concentration independent spectra for BIM peptides in 30% CH3CN:50 mM sodium phosphate (b) BIM peptides in 30% TFE indicating maximum helicity feasible for these peptide (note: MREs are of the same order of magnitude as the data reported in Figure  2b ).
Overexpression and Purification of Bcl-xL and Mcl-1
The pET28a His-SUMO Mcl-1 (172-327) and pET28a His-SUMO Bcl-xL (1-198, missing 26-81) constructs were over-expressed in the E. coli strain Rosetta 2. Cells were resuspended in 50mM TRIS pH 8.0, 500mM NaCl, 15mM Imidazole and lysed by sonication. The clarified lysate was applied to a 5ml HisTrap column equilibrated with 50mM TRIS pH 8.0, 500mM NaCl, 15mM
Imidazole. The HisTrap was then washed with 10 CV of 50mM TRIS pH 8.0, 500mM NaCl, 15mM
Imidazole followed by 10 CV 50mM TRIS pH 8.0, 500mM NaCl, 25mM Imidazole. The fusion proteins were eluted in 50mM TRIS pH 8.0, 500mM NaCl, 300mM Imidazole. TheHis-SUMO tag was removed in overnight in dialysis into 50mM TRIS pH 8.0, 250mM NaCl in the presence of Smt3 protease, Ulp1, overnight at 4°C. Uncleaved material and His-SUMO were removed by reapplication of the sample to a HisTrap in 50mM TRIS pH 8.0, 250mM NaCl and the flow through containing Mcl-1 or Bcl-xL collected. The proteins were then filtered before further purification on a Superdex 75 (GE healthcare) equilibrated in 50mM TRIS pH 8.0, 250mM NaCl, 0.5mM DTT, 2.5% Glycerol. Purified proteins were concentrated and stored at -80°C.
Fluorescence Anisotropy
The assays were performed as detailed in 10, 11 .
The buffers used for fluorescence anisotropy were either phosphate buffer (40 mM sodium 
FITC-BID/Mcl-1 and FITC-BID/Bcl-xL direct binding assays
For all variants of the labelled BID peptides (FITC-BID-WT,FITC-BID-MM, FITC-BID-DM and FITC-
BID-Aib), the direct binding assays were performed in Tris Buffer in 384 well plates. In protein titrations, the protein concentration started from between 1-10 µM and was diluted over 24 points in a 3/4 dilution regime, with the concentration of the labelled peptide fixed at 25-100 nM. In the peptide titrations, the concentration of the labelled peptides started from 5 µM and were diluted in a 2/3 regime over 24 points, with the concentration of the protein fixed at 50 nM. Plates were read after 2 hours of incubation, and read again after 4 and 18 hours to ensure complete equilibration.
Processing of fluorescence anisotropy data
Fluorescence anisotropy data was processed using Microsoft Excel to calculate intensity, anisotropy and fraction bound: As noted in an earlier paper by us, 12 fluorescence anisotropy competition assays including those used here tend not to follow a simple 1:1 competition arising as a consequence of non-specific interactions of the tracer (fluorescently labelled peptide) permitting determination of only an IC50. This is caused by the additional hydrophobicity of the fluorescein group resulting in a non-unity hill coefficient; the extent to which this occurs differs for different competitor peptide sequences. 
Supplementary Fluorescence Anisotropy assays
Co-crystallisation
Mcl-1 (172-327) was incubated at a 1:1.1 ratio with BID-MM overnight at 4°C in 100mM TRIS pH , with further refinement using PHENIX 20 and analysis with Molprobity.
21
Restraints for the non-natural linkages in the ligands were generate in Lidia. 18 Table S1 
Van't Hoff analysis of direct binding van't Hoff analysis of fluorescence anisotropy data
The van't Hoff analysis for the fluorescently labelled BID peptides was performed in 50 mM HEPES respectively. After incubation of the plate until the lower anisotropy plateau had equilibrated (~20 hours), the plates were scanned at 18 °C, then the temperature in the plate reader increased in steps of 5 °C, with a 10 minute equilibration time before the plate was read at each increasing temperature.
The data was processed as described previously and plotted as ln Ka against 1/T (K). 
Sequences of protein constructs
His-SUMO-Bcl-xL (1-198, missing residues 27-82) Sumo tag removed with Ulp1 during purification. 
atgggcagcagccatcatcatcatcatcacagcagcggcctggtgccgcgcggcagccat
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